Peptidylarginine Deiminase Type 2 Predicts Tumor Progression and Poor Prognosis in Patients with Curatively Resected Biliary Tract Cancer

SIMPLE SUMMARY: Biliary tract cancer (BTC) is a highly aggressive malignancy with a poor prognosis; currently, limited biomarkers are available for early diagnosis and effective disease management. Therefore, it is essential to investigate reliable biomarkers for BTC patients. Peptidylarginine deimi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Hon-Yi, Yu, Chih-Chia, Chi, Chen-Lin, Wei, Chang-Kuo, Yin, Wen-Yao, Tseng, Chih-En, Li, Szu-Chin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452823/
https://www.ncbi.nlm.nih.gov/pubmed/37627159
http://dx.doi.org/10.3390/cancers15164131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452823/
https://www.ncbi.nlm.nih.gov/pubmed/37627159
http://dx.doi.org/10.3390/cancers15164131

Ejemplares similares